SB 2297

Drugs, Prescription - As enacted, authorizes only a licensed physician to prescribe a buprenorphine product for an FDA-approved use in recovery or medication-assisted treatment; prohibits healthcare providers not licensed as physicians, and who are otherwise permitted to prescribe Schedule II or III drugs, from prescribing a buprenorphine product for the treatment of opioid use disorder unless the provider meets certain criteria; authorizes the health facilities commission to inspect facilities for compliance; requires the commission to report violations to the appropriate licensing authority. - Amends TCA Title 33; Title 53; Title 63 and Title 68.